Cargando…

Mapping Drug Prescription, Polypharmacy, and Pharmaceutical Spending in Older Adults in Iran: A Multilevel Analysis Based on Claims Data

Background: To date, comprehensive data on drug utilization in Iranian people are lacking. The purpose of this study was to graphically describe drug prescription, polypharmacy, and pharmaceutical spending in > 3 million Iranian elderly people. Methods: In this multilevel cross-sectional study, u...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamyari, Naser, Soltanian, Ali Reza, Mahjub, Hossein, Moghimbeigi, Abbas, Shahali, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127779/
https://www.ncbi.nlm.nih.gov/pubmed/35685196
http://dx.doi.org/10.47176/mjiri.35.175
_version_ 1784712427257987072
author Kamyari, Naser
Soltanian, Ali Reza
Mahjub, Hossein
Moghimbeigi, Abbas
Shahali, Zahra
author_facet Kamyari, Naser
Soltanian, Ali Reza
Mahjub, Hossein
Moghimbeigi, Abbas
Shahali, Zahra
author_sort Kamyari, Naser
collection PubMed
description Background: To date, comprehensive data on drug utilization in Iranian people are lacking. The purpose of this study was to graphically describe drug prescription, polypharmacy, and pharmaceutical spending in > 3 million Iranian elderly people. Methods: In this multilevel cross-sectional study, using administrative claims data provided by the Iran Health Insurance Organization (IHIO), we assessed drug claims and drug costs in 2018 in >3 million individuals living in Iran and who have been insured with health insurance (Bimeh Salamat). In particular, we analyzed the prevalence of polypharmacy and pharmaceutical spending use according to the annual Report of Iranian Health Insurance Organization. Multilevel ordinal logistic and multilevel beta regression models were used to analyze the data. Significance level was set as P ≤ .05 and CI at 95%. Results: Nationally, the mean number of drug prescriptions per patient was 1.46 (SD, 0.81). The mean number of prescribed drugs per patient was 4.32 (SD, = 3.04). The drug cost for each elderly patient was $6.86 (interquartile range (IQR), 12.26), with $4.96 and $1.76 for the insurance and the insured shares, respectively. For elderly women, the odds of polypharmacy (excessive and nonexcessive vs no polypharmacy) were 1.164 (95% CI, 1.142 to 1.186) times that of elderly men. In addition, in the spring season, the odds of polypharmacy were 1.274 (95% CI, 1.241 to 1.309) times that of the winter. Similarly, polypharmacy was strongly higher among patients who had noncommunicable diseases (OR, 2.174; 95% CI, 2.069 to 2.275 (P < 0.001)). Conclusion: The high prevalence of hyper prescription in Iran elderly people may indicate a need for interventions aiming at deprescribing drugs with an unfavorable benefit-risk profile. The best practice guidelines should be developed for improved medical practice in the prescription of medications for such a vulnerable population.
format Online
Article
Text
id pubmed-9127779
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Iran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-91277792022-06-08 Mapping Drug Prescription, Polypharmacy, and Pharmaceutical Spending in Older Adults in Iran: A Multilevel Analysis Based on Claims Data Kamyari, Naser Soltanian, Ali Reza Mahjub, Hossein Moghimbeigi, Abbas Shahali, Zahra Med J Islam Repub Iran Original Article Background: To date, comprehensive data on drug utilization in Iranian people are lacking. The purpose of this study was to graphically describe drug prescription, polypharmacy, and pharmaceutical spending in > 3 million Iranian elderly people. Methods: In this multilevel cross-sectional study, using administrative claims data provided by the Iran Health Insurance Organization (IHIO), we assessed drug claims and drug costs in 2018 in >3 million individuals living in Iran and who have been insured with health insurance (Bimeh Salamat). In particular, we analyzed the prevalence of polypharmacy and pharmaceutical spending use according to the annual Report of Iranian Health Insurance Organization. Multilevel ordinal logistic and multilevel beta regression models were used to analyze the data. Significance level was set as P ≤ .05 and CI at 95%. Results: Nationally, the mean number of drug prescriptions per patient was 1.46 (SD, 0.81). The mean number of prescribed drugs per patient was 4.32 (SD, = 3.04). The drug cost for each elderly patient was $6.86 (interquartile range (IQR), 12.26), with $4.96 and $1.76 for the insurance and the insured shares, respectively. For elderly women, the odds of polypharmacy (excessive and nonexcessive vs no polypharmacy) were 1.164 (95% CI, 1.142 to 1.186) times that of elderly men. In addition, in the spring season, the odds of polypharmacy were 1.274 (95% CI, 1.241 to 1.309) times that of the winter. Similarly, polypharmacy was strongly higher among patients who had noncommunicable diseases (OR, 2.174; 95% CI, 2.069 to 2.275 (P < 0.001)). Conclusion: The high prevalence of hyper prescription in Iran elderly people may indicate a need for interventions aiming at deprescribing drugs with an unfavorable benefit-risk profile. The best practice guidelines should be developed for improved medical practice in the prescription of medications for such a vulnerable population. Iran University of Medical Sciences 2021-12-27 /pmc/articles/PMC9127779/ /pubmed/35685196 http://dx.doi.org/10.47176/mjiri.35.175 Text en © 2021 Iran University of Medical Sciences https://creativecommons.org/licenses/by-nc-sa/1.0/This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial-ShareAlike 1.0 License (CC BY-NC-SA 1.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Kamyari, Naser
Soltanian, Ali Reza
Mahjub, Hossein
Moghimbeigi, Abbas
Shahali, Zahra
Mapping Drug Prescription, Polypharmacy, and Pharmaceutical Spending in Older Adults in Iran: A Multilevel Analysis Based on Claims Data
title Mapping Drug Prescription, Polypharmacy, and Pharmaceutical Spending in Older Adults in Iran: A Multilevel Analysis Based on Claims Data
title_full Mapping Drug Prescription, Polypharmacy, and Pharmaceutical Spending in Older Adults in Iran: A Multilevel Analysis Based on Claims Data
title_fullStr Mapping Drug Prescription, Polypharmacy, and Pharmaceutical Spending in Older Adults in Iran: A Multilevel Analysis Based on Claims Data
title_full_unstemmed Mapping Drug Prescription, Polypharmacy, and Pharmaceutical Spending in Older Adults in Iran: A Multilevel Analysis Based on Claims Data
title_short Mapping Drug Prescription, Polypharmacy, and Pharmaceutical Spending in Older Adults in Iran: A Multilevel Analysis Based on Claims Data
title_sort mapping drug prescription, polypharmacy, and pharmaceutical spending in older adults in iran: a multilevel analysis based on claims data
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127779/
https://www.ncbi.nlm.nih.gov/pubmed/35685196
http://dx.doi.org/10.47176/mjiri.35.175
work_keys_str_mv AT kamyarinaser mappingdrugprescriptionpolypharmacyandpharmaceuticalspendinginolderadultsiniranamultilevelanalysisbasedonclaimsdata
AT soltanianalireza mappingdrugprescriptionpolypharmacyandpharmaceuticalspendinginolderadultsiniranamultilevelanalysisbasedonclaimsdata
AT mahjubhossein mappingdrugprescriptionpolypharmacyandpharmaceuticalspendinginolderadultsiniranamultilevelanalysisbasedonclaimsdata
AT moghimbeigiabbas mappingdrugprescriptionpolypharmacyandpharmaceuticalspendinginolderadultsiniranamultilevelanalysisbasedonclaimsdata
AT shahalizahra mappingdrugprescriptionpolypharmacyandpharmaceuticalspendinginolderadultsiniranamultilevelanalysisbasedonclaimsdata